Taro Pharmaceutical Industries Stock Price Prediction
| TARO Stock | USD 42.19 0.05 0.12% |
Oversold Vs Overbought
49
Oversold | Overbought |
Taro Pharmaceutical stock price prediction is an act of determining the future value of Taro Pharmaceutical shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Taro Pharmaceutical's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Taro Pharmaceutical and does not consider all of the tangible or intangible factors available from Taro Pharmaceutical's fundamental data. We analyze noise-free headlines and recent hype associated with Taro Pharmaceutical Industries, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting Taro Pharmaceutical's stock price prediction:Quarterly Earnings Growth 1.782 | EPS Estimate Next Quarter 0.31 | EPS Estimate Current Year 1.1 | Wall Street Target Price 43 | EPS Estimate Current Quarter 0.3 |
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Taro Pharmaceutical based on different types of headlines from major news networks to social media. The Taro stock price prediction module provides an analysis of price elasticity to changes in media outlook on Taro Pharmaceutical over a specific investment horizon. Using Taro Pharmaceutical hype-based prediction, you can estimate the value of Taro Pharmaceutical Industries from the perspective of Taro Pharmaceutical response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Taro Pharmaceutical using Taro Pharmaceutical's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Taro using crowd psychology based on the activity and movement of Taro Pharmaceutical's stock price.
Taro Pharmaceutical Implied Volatility | 0.0 |
Taro Pharmaceutical's implied volatility exposes the market's sentiment of Taro Pharmaceutical Industries stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Taro Pharmaceutical's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Taro Pharmaceutical stock will not fluctuate a lot when Taro Pharmaceutical's options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Taro Pharmaceutical. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Taro Pharmaceutical to buy its stock at a price that has no basis in reality. In that case, they are not buying Taro because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Taro Pharmaceutical after-hype prediction price | USD 42.19 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Taro |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Taro Pharmaceutical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Taro Pharmaceutical After-Hype Price Prediction Density Analysis
As far as predicting the price of Taro Pharmaceutical at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Taro Pharmaceutical or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Taro Pharmaceutical, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Taro Pharmaceutical Estimiated After-Hype Price Volatility
In the context of predicting Taro Pharmaceutical's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Taro Pharmaceutical's historical news coverage. Taro Pharmaceutical's after-hype downside and upside margins for the prediction period are 41.50 and 42.88, respectively. We have considered Taro Pharmaceutical's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Taro Pharmaceutical is very steady at this time. Analysis and calculation of next after-hype price of Taro Pharmaceutical is based on 3 months time horizon.
Taro Pharmaceutical Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Taro Pharmaceutical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Taro Pharmaceutical backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Taro Pharmaceutical, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.69 | 0.00 | 0.00 | 9 Events / Month | 5 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
42.19 | 42.19 | 0.00 |
|
Taro Pharmaceutical Hype Timeline
Taro Pharmaceutical is at this time traded for 42.19. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Taro is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is projected to be very small, whereas the daily expected return is at this time at 0.0%. %. The volatility of related hype on Taro Pharmaceutical is about 104.28%, with the expected price after the next announcement by competition of 42.19. About 78.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.89. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Taro Pharmaceutical last dividend was issued on the 10th of December 2018. The entity had 2:1 split on the 27th of July 2001. Given the investment horizon of 90 days the next projected press release will be in about 9 days. Check out Taro Pharmaceutical Basic Forecasting Models to cross-verify your projections.Taro Pharmaceutical Related Hype Analysis
Having access to credible news sources related to Taro Pharmaceutical's direct competition is more important than ever and may enhance your ability to predict Taro Pharmaceutical's future price movements. Getting to know how Taro Pharmaceutical's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Taro Pharmaceutical may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ALKS | Alkermes Plc | 0.36 | 9 per month | 0.00 | (0.09) | 2.79 | (4.24) | 21.89 | |
| IRWD | Ironwood Pharmaceuticals | 0.31 | 12 per month | 0.00 | (0.10) | 3.82 | (4.53) | 42.91 | |
| DCPH | Deciphera Pharmaceuticals LLC | (0.12) | 10 per month | 2.52 | (0.02) | 4.84 | (4.32) | 17.94 | |
| EGRX | Eagle Pharmaceuticals | (0.40) | 10 per month | 4.87 | 0.03 | 8.00 | (7.92) | 23.10 | |
| NBIX | Neurocrine Biosciences | 4.08 | 10 per month | 1.56 | (0.04) | 2.61 | (2.36) | 8.06 | |
| DVAX | Dynavax Technologies | (0.26) | 9 per month | 0.00 | (0.27) | 2.49 | (2.90) | 6.78 |
Taro Pharmaceutical Additional Predictive Modules
Most predictive techniques to examine Taro price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Taro using various technical indicators. When you analyze Taro charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Taro Pharmaceutical Predictive Indicators
The successful prediction of Taro Pharmaceutical stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Taro Pharmaceutical Industries, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Taro Pharmaceutical based on analysis of Taro Pharmaceutical hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Taro Pharmaceutical's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Taro Pharmaceutical's related companies. | 2020 | 2021 | 2022 | 2024 (projected) | Days Sales Outstanding | 177.45 | 199.42 | 165.3 | 104.54 | PTB Ratio | 1.65 | 0.95 | 0.53 | 3.72 |
Story Coverage note for Taro Pharmaceutical
The number of cover stories for Taro Pharmaceutical depends on current market conditions and Taro Pharmaceutical's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Taro Pharmaceutical is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Taro Pharmaceutical's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
View All Premium Stories
Taro Pharmaceutical Short Properties
Taro Pharmaceutical's future price predictability will typically decrease when Taro Pharmaceutical's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Taro Pharmaceutical Industries often depends not only on the future outlook of the potential Taro Pharmaceutical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Taro Pharmaceutical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 37.6 M | |
| Cash And Short Term Investments | 850.3 M |
Check out Taro Pharmaceutical Basic Forecasting Models to cross-verify your projections. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Complementary Tools for Taro Stock analysis
When running Taro Pharmaceutical's price analysis, check to measure Taro Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Taro Pharmaceutical is operating at the current time. Most of Taro Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Taro Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Taro Pharmaceutical's price. Additionally, you may evaluate how the addition of Taro Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |
Is Taro Pharmaceutical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Taro Pharmaceutical. If investors know Taro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Taro Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.782 | Earnings Share 1.22 | Revenue Per Share 16.252 | Quarterly Revenue Growth 0.129 | Return On Assets 0.0103 |
The market value of Taro Pharmaceutical is measured differently than its book value, which is the value of Taro that is recorded on the company's balance sheet. Investors also form their own opinion of Taro Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Taro Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Taro Pharmaceutical's market value can be influenced by many factors that don't directly affect Taro Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Taro Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Taro Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Taro Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.